Home-based visual field testing for glaucoma patients
Official title: Clustered home assessment of visual fields in patients with glaucoma
Funded at Vivid Vision, INC. · NIH-10928712 · Data updated 2026-11-12
This study is testing a new, easy way for people with glaucoma to check their vision at home using a virtual reality headset, so they can keep track of any changes in their eyesight more often and get the help they need faster.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vivid Vision, INC. NIH-funded |
| Lab location | 1 site (San Francisco, UNITED STATES) |
| Project start | September 30, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $786,367 |
| NIH project number | 5R44EY035203-02 |
| Project ID | NIH-10928712 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are glaucoma patients who require regular monitoring of their visual fields.
✕Less likely to help
Patients with stable vision who do not have glaucoma may not receive any benefit from this research.
What this research studies
This research focuses on improving the way glaucoma patients monitor their vision by developing a home-based visual field test called Vivid Vision Perimetry (VVP-10). Using a low-cost virtual reality headset, patients can perform the test in a user-friendly manner, allowing for more frequent data collection compared to traditional methods. The goal is to detect any progression of visual field loss quickly, which is crucial for timely treatment. This approach aims to reduce patient anxiety about their vision stability and improve overall management of glaucoma.
Why it matters
Potential benefit: If successful, this research could provide glaucoma patients with a more accessible and efficient way to monitor their vision, leading to better treatment outcomes.
How similar studies have gone: Other research has shown promise in using virtual reality for medical testing, indicating that this approach could be effective.
Where this research is happening
-
Vivid Vision, INC.
San Francisco, United States Active
Researchers
- Principal investigator: Backus, Benjamin T — Vivid Vision, INC.
- Study coordinator: Backus, Benjamin T
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Comparing tube positions in glaucoma implants to protect corneal cells
This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.
-
Automated topographic test for glaucoma detection and progression
A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.
-
Using AI on eye scans and genes to predict glaucoma risk
This project uses artificial intelligence on eye scans, vision tests, and genetic information to find people most likely to develop or have worsening glaucoma.
-
AI-based glaucoma screening in community health centers
A new, easy-to-use AI screening approach will be tested in federally funded health centers to help identify people at risk for glaucoma, especially in communities with higher risk.
-
Understanding how glaucoma genes control eye cell function
A long-term research project will study how genetic factors affect eye cells in adults with glaucoma to uncover new ideas for protecting vision.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.